Prof. Kim to nominate a head of multinational clinical study.

Published: 2006-04-12 06:58:00

Updated: 2006-04-12 06:58:00

Prof. Kim Seon-woo of Sungkyunkwan Univ. Medical College Kangbuk Samsung hospital, was nominated as the chief of the multinational clinical studies (145 centers from 8 countries including Korea and the United States) of Galvus (vildagliptin), a new type of anti-diabetic drug developed by Novartis.

In the meantime, Prof. Oh Byeong-hee of SNU Medical College hospital was nominated last year as...

Fees

- Email service daily and homepage access.

$300 per month.
5 Email holders per each company.
Anual contract base.